Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.16 - $100.0 $1,423 - $889,500
-8,895 Reduced 14.72%
51,552 $8,000
Q2 2022

Aug 12, 2022

SELL
$0.2 - $0.5 $9,652 - $24,131
-48,262 Reduced 44.4%
60,447 $24,000
Q1 2022

May 16, 2022

SELL
$0.41 - $0.63 $130,846 - $201,057
-319,139 Reduced 74.59%
108,709 $59,000
Q4 2021

Feb 08, 2022

BUY
$0.57 - $1.29 $221,794 - $501,955
389,113 Added 1004.55%
427,848 $249,000
Q3 2021

Nov 15, 2021

BUY
$1.11 - $1.7 $4,582 - $7,017
4,128 Added 11.93%
38,735 $47,000
Q2 2021

Sep 13, 2021

BUY
$1.46 - $2.25 $50,526 - $77,865
34,607 New
34,607 $59,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.